Vitamin D2 O-t-Butyldimethylsilyl Ether

IMPURITIES

Product Details

CAT No.# CS-T-87969
Category Impurities
CAS 104846-62-0
Molecular Weight 51.91
Molecular Formula C₃₄H₅₈OSi
Solubility: DCM, Hexanes
Appearance: Light Yellow Oil
Synonyms: (1R,3aS,4E,7aR)-4-[(2Z)-2-[(5S)-5-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-7a-methyl-1-[(1R,2E,4R)-1,4,5-trimethyl-2-hexen-1-yl]-1H-indene; (1,1-Dimethylethyl)[[(3β,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-t袈袈袈袈
Application Notes: Vitamin D2 O-t-Butyldimethylsilyl Ether is an impurity of Vitamin D2, which is a synthetic form of Vitamin D. Prepared from ergosterol by UV irradiation in a suitable solvent. Commercial solutions are usually made with propylene glycol or sesame oil. Antirachitic. Vitamin D2 O-t-Butyldimethylsilyl Ether is also an intermediate in synthesizing (7Z)-Calcipotriene, which is an isomeric impurity of Calcipotriene (1442000), a vitamin D3 analogue with low calcemic activity.
COA / MSDS:    View COA    MSDS    Enquire
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
PEOPLE ALSO SEARCHED FOR: 1. (6R,7S)-7-(2-chloroacetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
2. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
3. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
4. Benidipine D7
5. Lauroside D
6. Triazolam 13C D3
7. Icatibant impurity 1
8. BISPHENOL AF (RING-13C12)
9. 0.1% TFA in Water ULC-MS
10. Metamizole EP Impurity C HCl
11. Silodosin Metabolite D4
12. Brivaracetam Carboxylic acid metabolite [UCB 42145]
13. Terbuthylazine D5
14. tibolone (848)
15. (Z)-Dimethylvinphos
16. Silodosin Metabolite
17. 2-Phenoxymethanesulfonanilide
18. Nimesulide EP Impurity A
19. Acetone HPLC
20. Nandrolone Decanoate EP impurity F




This page contains information about Vitamin D2 O-t-Butyldimethylsilyl Ether Cas 104846-62-0 and its Impurities.
"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."